TWST – twist bioscience corporation (US:NASDAQ)

News

Twist Bioscience (TWST) had its "overweight" rating reaffirmed by Barclays PLC.
Twist Bioscience (TWST) had its price target raised by Guggenheim from $50.00 to $55.00. They now have a "buy" rating on the stock.
Twist Bioscience (TWST) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
Assessing Twist Bioscience (TWST) Valuation After Insider Sale And Recent Q1 FY26 Optimism [Yahoo! Finance]
Twist Bioscience Adds Invenra Bispecific Platform To Broaden Discovery Opportunity [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com